Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid: a Multicenter Retrosepctive Study

NCT05649579 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05649579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05649579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid: a Multicenter Retrosepctive Study
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
January 31, 2023
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous pemphigoid